ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 139 filers reported holding ACCELERON PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,056,000 | +3.3% | 276,525 | +46.5% | 0.00% | 0.0% |
| Q3 2016 | $6,830,000 | +5.2% | 188,731 | -1.2% | 0.00% | 0.0% |
| Q2 2016 | $6,492,000 | +28.7% | 191,044 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $5,045,000 | -11.5% | 191,173 | +63.6% | 0.00% | 0.0% |
| Q4 2015 | $5,699,000 | +97.2% | 116,888 | +0.7% | 0.00% | +50.0% |
| Q3 2015 | $2,890,000 | -17.2% | 116,042 | +5.2% | 0.00% | 0.0% |
| Q2 2015 | $3,491,000 | -8.3% | 110,328 | +10.3% | 0.00% | 0.0% |
| Q1 2015 | $3,808,000 | +9.5% | 100,053 | +12.0% | 0.00% | 0.0% |
| Q4 2014 | $3,479,000 | +110.6% | 89,301 | +63.5% | 0.00% | +100.0% |
| Q3 2014 | $1,652,000 | -10.1% | 54,626 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,838,000 | -3.0% | 54,100 | -1.5% | 0.00% | 0.0% |
| Q1 2014 | $1,895,000 | +13.7% | 54,907 | +30.4% | 0.00% | 0.0% |
| Q4 2013 | $1,667,000 | – | 42,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |